Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 3:41 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 529–552 of 1,819 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Media Clear all

Conditions: Achondroplasia
Interventions: Recifercept; Biological
Lead sponsor: Pfizer; Industry
Eligibility: 15 Months to 12 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 6
States / cities: Irvine, California • Long Beach, California • Torrance, California + 2 more

Conditions: Cardiovascular Disease, Cigarette Smoking
Interventions: Subject's usual brand (UB) tobacco product; Other
Lead sponsor: R.J. Reynolds Tobacco Company; Industry
Eligibility: 26 Years to 49 Years · Male only
Enrollment: 168 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Lincoln, Nebraska

Conditions: Pain, Acute Otitis Media
Interventions: Benzocaine Otic Solution, Placebo; Drug
Lead sponsor: Lachlan Pharma Holdings; Industry
Eligibility: 5 Years to 12 Years
Enrollment: 141 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: Gresham, Oregon

Conditions: Concussion, Brain
Interventions: [11C] PiB, [18F] PBR111, [18F] Flortaucipir; Drug
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 50 Years to 70 Years · Male only
Enrollment: 250 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2028
U.S. locations: 3
States / cities: Waltham, Massachusetts • Chapel Hill, North Carolina • Milwaukee, Wisconsin

Conditions: Alzheimer Disease
Interventions: Memesto; Device
Lead sponsor: Edgewater Safety Systems, Inc.; Industry
Eligibility: Not listed
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Depression
Interventions: Web-App based Lifestyle Physical Activity Promotion Program, The Centers for Disease Control and Prevention (CDC) website on depression and physical activity guidelines; Behavioral
Lead sponsor: Vanderbilt University; Other
Eligibility: 40 Years to 60 Years · Female only
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Cannabis Use
Interventions: Behavioral: Smart Talk Cannabis Awareness and Prevention; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 10 Years to 20 Years
Enrollment: 10,800 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Healthy
Interventions: Ecopipam immediate release form, 90 mg controlled release form, 180 mg controlled release form; Drug
Lead sponsor: Emalex Biosciences Inc.; Industry
Eligibility: 18 Years to 45 Years · Male only
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Malignant Neoplasm
Interventions: Activity Monitor, Media Intervention; Other
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 2
States / cities: Los Angeles, California

Conditions: Anosmia, Skull Base Neoplasms
Interventions: Olfactory training, Placebo training; Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Reproductive Behavior, Sexual Behavior, Adolescent Behavior, Contraception
Interventions: Dr. Erica; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 14 Years to 19 Years · Female only
Enrollment: 146 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Intracranial Aneurysms, Saccular Aneurysm
Interventions: Not listed
Lead sponsor: Semmes-Murphey Foundation; Other
Eligibility: 18 Years to 80 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Pelvic Organ Prolapse, Pelvic Organ Prolapse (POP), Pelvic Organ Prolapse Vaginal Surgery, Pelvic Organ Prolapse, Patient Education
Interventions: Postoperative Exercise regimen; Behavioral
Lead sponsor: NICHD Pelvic Floor Disorders Network; Network
Eligibility: 18 Years to 99 Years · Female only
Enrollment: 288 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 7
States / cities: San Diego, California • Chicago, Illinois • Durham, North Carolina + 3 more

Conditions: Suicide, Distress, Emotional
Interventions: Treatment as usual, Barrier Reduction Intervention; Behavioral
Lead sponsor: Harvard University; Other
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Myopia, Hyperopia, Presbyopia
Interventions: omafilcon A lens, Low ADD power somofilcon A lens, Medium ADD power somofilcon A lens, High ADD power somofilcon A lens; Device
Lead sponsor: CooperVision International Limited (CVIL); Industry
Eligibility: 18 Years and older
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Berkeley, California

Conditions: Non-small Cell Lung Cancer (NSCLC)
Interventions: iSABR, 25 Gray in 1 fraction for small peripheral tumors, iSABR, 50 Gray in 4 fractions for medium peripheral tumors, iSABR, 54 Gray in 3 fractions for large peripheral tumors, iSABR, 40 Gray in 4 fractions for small central tumors, iSABR, 50 Gray in 4 fractions for medium central tumors, iSABR, 60 Gray in 8 fractions for large central tumors; Radiation
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 256 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2022
U.S. locations: 2
States / cities: Stanford, California • Seattle, Washington

Conditions: Asthma
Interventions: Fluticasone propionate, Placebo, BI 54903; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 12 Years to 65 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011
U.S. locations: 41
States / cities: Fountain Valley, California • Huntington Beach, California • Long Beach, California + 36 more

Conditions: Wellness, Health
Interventions: Geranylgeraniol 300 mg, Placebo; Dietary Supplement
Lead sponsor: Designs for Health; Industry
Eligibility: 40 Years to 65 Years
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Palm Coast, Florida

Conditions: Nipah Virus Infection
Interventions: PHV02, Lactated Ringer's; Biological
Lead sponsor: Public Health Vaccines LLC; Industry
Eligibility: 18 Years to 59 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 3
States / cities: Anaheim, California • Hollywood, Florida • Salt Lake City, Utah

Conditions: Social Isolation, Loneliness
Interventions: Experimental Health Communication, Simulated Social Media Platform Only; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 29 Years
Enrollment: 1,900 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Obesity, Diabetes Mellitus, Type 2, Appetitive Behavior
Interventions: Pearl millet couscous - made in Senegal, Pearl millet couscous - made in USA, Pearl millet thick porridge, Wheat couscous, White rice; Other
Lead sponsor: Purdue University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: West Lafayette, Indiana

Conditions: Cancer
Interventions: 4 Corners Rural Health Cancer Prevention; Behavioral
Lead sponsor: Klein Buendel, Inc.; Industry
Eligibility: 18 Years to 26 Years
Enrollment: 1,796 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 5
States / cities: Tucson, Arizona • Aurora, Colorado • Fort Collins, Colorado + 2 more

Conditions: Migraine
Interventions: Stage 1: Naltrexone/Acetaminophen, Stage 1: Naltrexone, Stage 1: Acetaminophen, Stage1: Placebo, Stage 2: Naltrxone/Acetaminophen high dose, Stage 2: Naltrexone/Acetaminophen medium dose, Stage 2: Naltrxone/Acetaminophen low dose, Stage 2: Placebo; Drug
Lead sponsor: Allodynic Therapeutics, Inc; Industry
Eligibility: 18 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: North Miami, Florida

Conditions: HIV, Mental Health, Substance Use, STI
Interventions: Automated Messaging & Monitoring, Peer Support, Coaching; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 12 Years to 24 Years
Enrollment: 1,478 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2022
U.S. locations: 2
States / cities: Los Angeles, California • New Orleans, Louisiana

Search by objective public record fields.

Continuation Study of Long-term Safety, Tolerability, Pharmacokinetics and Efficacy of Recifercept in Achondroplasia

Cardiovascular Disease Biomarkers in Smokers and Moist Snuff Consumers

Phase III Study Evaluating Topical Benzocaine for Treatment of Acute Otitis Media in Children

NFL LONG Prospective Study

Memesto Wearable Device for Persons With Dementia

To Improve Depressive Symptoms Using a Web-App

Smart Talk: Cannabis Awareness and Prevention Curriculum Evaluation

Safety and Tolerability Comparison of Immediate and Controlled Release Formulations of Ecopipam

Movement and Fitness Trackers in Determining Performance Status

Chemosensory Dysfunction and Recovery in Endoscopic Endonasal Skull Base Surgery

Reducing Teen Pregnancy in the Emergency Department

PC400 Coils for Treatment of Intracranial Aneurysms

Accelerometer Measured Early Recovery After Prolapse Surgery

Brief Interventions on Social Media to Reduce Suicide Risk (Intervention 3)

A Clinical Comparison of Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add

Individualized Lung Tumor Stereotactic Ablative Radiotherapy (iSABR)

Dose Finding Study on BI54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat® Inhaler in Asthmatic Patients Inadequately Controlled on Short-acting-beta-agonist (SABA) Therapy

A Crossover Clinical Trial Investigating the Effects of Geranylgeraniol (GG) Supplementation on Testosterone Levels in Healthy Men and Women Over an 18-week Period

Study to Evaluate Safety and Immunogenicity of a Prime-Boost Regimen of rVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects

Keep Social Study for Young Adults

Digestive Properties of Carbohydrate-based Foods

Cancer Prevention for Young Rural Adults

Single-Site Study of Naltrexone/Acetaminophen for the Acute Treatment of Migraine: A Phase 2 Randomized Trial

Engaging Seronegative Youth to Optimize HIV Prevention Continuum